Previous Article | Next Article 
Journal of Virology, March 2001, p. 2067-2075, Vol. 75, No. 5
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.5.2067-2075.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Transcriptional Analysis of Marek's Disease Virus
Glycoprotein D, I, and E Genes: gD Expression Is Undetectable in
Cell Culture
Xinyu
Tan,*
Peter
Brunovskis,
and
Leland F.
Velicer§
Department of Microbiology, Michigan State
University, East Lansing, Michigan 48824-1101
Received 19 June 2000/Accepted 6 November 2000
 |
ABSTRACT |
The various alphaherpesviruses, including Marek's disease virus
(MDV), have both common and unique features of gene content and
expression. The entire MDV Us region has been sequenced in our laboratory (P. Brunovskis and L. F. Velicar, Virology
206:324-338, 1995). Genes encoding the MDV glycoprotein D (gD),
glycoprotein I (gI), and glycoprotein E (gE) homologs have been found
in this region, although no gG homolog was found. In this work,
transcription of the tandem MDV gD, gI, and gE genes was studied and
found to have both unique characteristics and also features in common
with other alphaherpesviruses. MDV gD could not be immunoprecipitated from MDV GA-infected duck embryo fibroblast cells by antisera reactive
to its TrpE fusion proteins, while gI and gE could be. When the gD gene
was subjected to in vitro-coupled transcription-translation, the
precursor polypeptide was produced and could be immunoprecipitated by
anti-gD. Northern blot, reverse transcriptase PCR, and RNase protection
analyses have shown that (i) no mRNA initiating directly from the gD
gene could be detected; (ii) a large but low-abundance 7.5-kb
transcript spanning five genes, including the one encoding gD, was seen
on longer exposure; and (iii) transcription of the gI and gE genes
formed an abundant bicistronic 3.5-kb mRNA, as well as an abundant
2.0-kb gE-specific mRNA. Therefore, the MDV gD gene expression is
down-regulated at the transcription level in MDV-infected cell culture,
which may be related to the cell-associated nature of MDV in fibroblast
cells. Compared to the highly gD-dependent herpes simplex virus and the
other extreme of the varicella-zoster virus which lacks the gD gene,
MDV is an intermediate type of alphaherpesvirus.
 |
INTRODUCTION |
Marek's disease virus (MDV) is a
highly infectious herpesvirus which induces lymphomas in chickens. The
nonpathogenic and antigenically related herpesvirus of turkey (HVT) is
usually effective as a vaccine against Marek's disease and is the
first successful vaccine against a naturally occurring tumor of any
species. While being a very interesting and valuable natural host
animal model for oncogenesis, this cell-associated herpesvirus system
is somewhat complex. Fully enveloped infectious virions are produced
only in feather follicle epithelium (FFE) of the skin; they then detach with feather dander, contaminate dust, are spread by the airborne route, and infect new hosts via the respiratory tract. Four phases of
infection in vivo can be delineated: (i) early productive-restrictive virus infection causing primarily degenerative changes, (ii) latent infection, (iii) a second phase of cytolytic infection coincident with
permanent immunosuppression, and (iv) a proliferative phase involving
nonproductively infected lymphoid cells that may progress to the point
of lymphoma formation (5).
MDV and HVT have genome structures closely resembling those of
alphaherpesviruses such as herpes simplex virus type 1 (HSV-1), the
prototype alphaherpesvirus, varicella-zoster virus (VZV), pseudorabies
virus (PRV), bovine herpesvirus 1 (BHV-1), and equine herpesvirus 1. The alphaherpesvirus genome structure consists of covalently joined
long (L) and short (S) components. The S component comprises a unique
short (Us) segment flanked by a pair of inverted repeat
regions. There are four glycoprotein genes in the HSV-1 Us
region, encoding glycoproteins G (gG), D (gD), I (gI), and E (gE)
(10).
HSV-1 gD is a virion envelope component which plays an essential role
in HSV-1 entry into susceptible mammalian cells (15). HSV-1 gD has been implicated in receptor binding, cell fusion, and
neuroinvasiveness (11). Immunization of animals with HSV-1 gD stimulates the production of virus-neutralizing antibodies and
protects them from both lethal challenge with HSV-1 and the establishment of latency (4). Homologs of HSV-1 gD have
been identified in the genomes of PRV and BHV-1, among other
alphaherpesviruses. The gDs of HSV-1, PRV, and BHV-1 cause viral
interference (7, 16, 27). Although the gD homolog of PRV
is essential for penetration, its production is not required for
cell-to-cell spread (26).
The gI and gE homologs of HSV-1, PRV, and VZV are found to form
complexes. HSV-1 gE and VZV gE act as immunoglobulin G Fc receptors
that may utilize an antibody bipolar bridging mechanism to protect
virus-infected cells from antibody-dependent cellular cytotoxicity
(14, 20). HSV-1 and PRV gE are involved in neurotropism and virulence during virus infection of animals (6, 23).
The entire MDV Us region has been sequenced in our
laboratory (3). Genes encoding the MDV gD, gI, and gE
homologs have been found in this region, although no gG homolog was
found. Antisera to their TrpE fusion proteins have been produced (see
Fig. 1). MDV gI and gE have been identified in MDV-infected cells by
immunoprecipitation with their respective antisera (2). In
contrast, no gD was found in MDV-infected cells with antisera to its
TrpE fusion proteins (2).
In this study, antiserum to TrpE-gD was used in a further attempt to
detect MDV gD expression in MDV-infected cells, but no protein of the
predicted size was found. When Northern blot, reverse transcriptase PCR
(RT-PCR) and RNase protection analyses were performed, an abundant
3.5-kb bicistronic mRNA including the MDV gI and gE genes was detected,
together with an abundant 2.0-kb monocistronic transcript specific for
the gE gene. In contrast, there was no specific mRNA initiating from
the gD gene promoter, although a low-abundance polycistronic mRNA
including the MDV US3, SORF4, gD, gI, and gE genes was found.
(Preliminary results of this work were presented at the 1996 International Symposium on Marek's Disease.)
 |
MATERIALS AND METHODS |
Cells and viruses.
The preparation, propagation, and
infection of duck embryo fibroblast (DEF) and chicken embryo fibroblast
(CEF) cells with cell-associated MDV were performed as described
previously (8). The virulent MDV GA strain used in this
study was at cell culture passage level 6 following isolation of
cell-free virus from feather tips obtained from infected birds with
symptoms of Marek's disease.
Generation of TrpE fusion proteins and antibodies to fusion
proteins.
The vector system used to express the MDV genes in
Escherichia coli consists of a group of plasmids (pATH
vectors) encoding approximately 37 kDa of the bacterial TrpE open
reading frame (ORF) product under control of the inducible
trp operon promoter. A polylinker with multiple cloning
sites at the 3' end of the trpE ORF allows in-frame
insertion of foreign ORFs. The TrpE fusion proteins were generated as
described previously (8). The fusion proteins were
purified from preparative sodium dodecyl sulfate (SDS)-7.5%
polyacrylamide gels and used to prepare antisera by injecting rabbits
as described previously (8).
In vitro transcription and translation.
MDV SORF4, gD, gI,
and gE genes were cloned downstream of T3 or T7 promoters. In
vitro-coupled transcription-translation was performed with Promega's
TNT coupled reticulocyte lysate system.
Radiolabeling of proteins and immunoprecipitation analysis.
MDV-infected and mock-infected control DEF cells were labeled with
[35S]methionine at 72 h postinfection for 4 h. After
labeling was complete, culture medium samples and cell lysates were
prepared and immunoprecipitation analysis was carried out as previously described (8). Briefly, 400 µl of
35S-labeled cell lysates were pretreated with normal rabbit
serum for 2 h, protein A was added, and the mixture was incubated
for 1 h and centrifuged. After centrifugation, the supernatants
were mixed with the respective antisera for 2 h. Then protein
A-Sepharose was added, and the suspension was incubated with gentle
mixing for 2 h, followed by centrifugation. Immunoprecipitates
were resuspended in sample buffer, recentrifuged, and subjected to
SDS-polyacrylamide gel electrophoresis (PAGE). Protein markers (GIBCO)
were used as molecular weight standards.
RNA preparation, isolation, and Northern blot analysis.
RNAs
were prepared from MDV-infected and mock-infected control cells at
72 h postinfection by the guanidinium isothiocyanate-phenol extraction procedure. Poly(A)+ RNAs were prepared by
oligo(dT) cellulose spin columns. Northern blot analysis was performed
as described previously (29). DNA probes were labeled by
the random-priming method. Riboprobes were prepared as described below.
Transcript size determinations were based on a comparison with a GIBCO
RNA ladder run in parallel.
Riboprobe and RNA marker preparation.
Antisense riboprobes
and RNA marker were generated by in vitro transcription off linearized
plasmid templates with RNA polymerase T3 or T7 (Promega). For
riboprobes and RNA markers used in RNase protection, the 20-µl
reaction solution included 5 mM each GTP, ATP, and CTP, in addition to
4.5 µl of [
-32P]UTP (800 µCi/mmol). For riboprobes
used in Northern blot analysis, 50 µM unlabeled UTP was added to the
reaction mixture.
To determine the size of the protected fragments, a set of RNA markers
was generated in the proper range. The pBCSK(+) plasmid (Stratagene)
was cut by BamHI, XhoI, HinfI, or
PvuII, and RNA fragments of 51, 102, 139 and 245 bases were
produced, respectively. The RNA marker was a mixture of the four
radiolabeled RNA fragments.
RNase protection analysis.
A 500,000-cpm portion of a
riboprobe was hybridized with 40 µg of total RNA in 20 µl of
hybridization buffer (40 mM PIPES [pH6.4], 1 mM EDTA, 0.4 M NaCl,
80% formamide) and incubated at 42°C overnight. The hybridization
solution was diluted with 300 µl of digestion buffer (300 mM NaCl, 10 mM Tris-HCl [pH7.5], 5 mM EDTA, 40 µg of RNase A per ml, 800 U of
RNase T1 per ml) and incubated at 30°C for 60 min. After
digestion, the samples were extracted with phenol-chloroform and the
RNAs were precipitated in ethanol. The pellets were then resuspended in
loading buffer and subjected to electrophoresis on a
polyacrylamide-urea sequencing gel.
RT-PCR assays.
Total RNA preparations were treated with
RNase-free DNase I (10 U per mg of total RNA) for 30 min at 37°C.
Reverse transcription was performed with Superscript II RT (GIBCO)
using the oligo(dT) primer. This reaction mixture (1/10 aliquot) was
subjected to 30 cycles of PCR consisting of 94°C for 1 min, 50°C
for 2 min, and 72°C for 3 min. The product (1/10 aliquot) was loaded
onto agarose gels for electrophoresis, and DNA was visualized with ethidium bromide. Nucleotide positions of the primers are shown in Fig.
5A. Primer D sense (DS) (5' TACGTGAATATGCCAACTGC 3')
corresponded to nucleotide positions 7340 to 7359. Primer D
antisense (DA) (5' AGTGAGTCCAGTGTAACCATCC 3') corresponded
to nucleotide positions 7875 to 7896. Primer I sense (IS) (5'
TGGTATATGCTCAACCTCATGG 3') corresponded to nucleotide positions
8574 to 8595. Primer I antisense (IA) (5' ACCGATGTATATCCTACGATGG
3') corresponded to nucleotide positions 8574 to 8595. Primer E
sense (ES) (5' GAATCGCTAAGTCTGAATGG 3') corresponded to
nucleotide positions 9791 to 9800. Primer E antisense (EA) (5'
CAGAATGTCAATGTTGGATGCG 3') corresponded to nucleotide positions
10249 to 10270.
 |
RESULTS |
Immunoprecipitation analysis fails to detect MDV gD in MDV-infected
cell culture.
Of the 11 MDV Us genes, 7 are HSV-1
homologs: US1, US10, US2, US3, US6, (gD), US7 (gI), and US8 (gE).
Fragments from each gene have been cloned in-frame with trpE
to make TrpE fusion proteins (Fig. 1).
Antisera to each TrpE fusion protein have been produced. With these
antisera, the proteins encoded by MDV US1, US10, US2, US3, US7 (gI),
and US8 (gE) have been identified in extracts from MDV-infected DEF
cells, but no gD (US6) protein was found (2).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of the MDV US
region DNA fragments used for antibody production and Northern blot
analysis. The nucleotide position numbers are as previously published
(3). Each bar represents an MDV Us region
fused to TrpE protein for antibody production. Arrows indicate
fragments also used as DNA probes specific for the gD, gI, and gE
regions of the transcripts in Northern blot analysis.
|
|
In further attempts to identify possible low levels of MDV gD
expression, immunoprecipitation and SDS-PAGE analysis were performed with rabbit anti-gD antibody and radiolabeled proteins from MDV GA-infected DEF cells. Anti-gI, anti-gE, and anti-gB antibodies were
used as positive controls. Normal rabbit serum (NRS) was used as a
negative control. Anti-gE immunoprecipitated the two glycosylated forms
of MDV gE (gp62 and gp72) (Fig. 2, lane
8), and anti-gI immunoprecipitated both MDV gI and gE (lane 6), as reported previously (2). Anti-gB immunoprecipitated MDV gB (lane 10) (8).

View larger version (77K):
[in this window]
[in a new window]
|
FIG. 2.
MDV gD is not expressed in MDV-infected DEF cells.
Lanes: 1, 3, 5, 7, and 9, mock-infected DEF cells; 2, 4, 6, 8, and 10:
MDV GA-infected DEF cells; 1 and 2, immunoprecipitation analysis with
NRS; 3, and 4, immunoprecipitation analysis with anti-gD; 5 and 6, immunoprecipitation analysis with anti-gI; 7 and 8, immunoprecipitation
analysis with anti-gE; 9 and 10, immunoprecipitation analysis with
anti-gB. The illustration shows a 4-day exposure.
|
|
The MDV gD precursor polypeptide was predicted to be about 43 kDa
(3). Based on its predicted amino acid sequence, gD has four potential N-linked glycosylation sites, resulting in a mature glycoprotein predicted to be about 53 kDa. However, no protein in the
range of 40 to 60 kDa was immunoprecipitated with anti-gD (Fig. 2 lane
4). A fourfold-longer exposure of the same gel still did not show any
MDV-specific protein in that range (data not shown). When the same
experiment was done in MDV GA-infected CEF cells instead of DEF cells,
the same result was observed (data not shown).
An MDV-specific protein of about 79 kDa was nonspecifically trapped by
anti-gD, anti-gI, anti-gE, and anti-gB antibodies (Fig. 2, lanes 4, 6, 8, and 10). A fourfold-longer exposure showed that it also could be
trapped by NRS (data not shown). Thus, the 79-kDa protein seen in this
gel is most probably the p79 reported by this laboratory previously
(13). It was recognized as a sticky protein which could be
nonspecifically trapped by either NRS or specific-pathogen-free chicken
serum from MDV- or HVT-infected cells but not from mock-infected cells.
The gene encoding p79 has been sequenced (9), and it is
not the gD gene.
Similar experiments have been done with extracts from MDV Md5-infected,
Md11-infected, and JM/102w-infected DEF cells, and no gD expression was
detected (unpublished data). Therefore, the absence of a detectable
level of gD expression in MDV-infected cell culture is not GA strain specific.
The MDV gD gene encodes a functional protein.
Failure to
detect gD expression could result from a defective ORF; the presumed gD
ORF may not encode an authentic protein. To address this question, the
MDV gD gene, as well as the SORF4, gI, and gE genes as controls, was
cloned downstream of T3 or T7 promoters, and in vitro coupled
transcription-translation was performed with T3 or T7 RNA polymerases
and rabbit reticulocyte lysate (Promega). Each of the SORF4, gD, gI,
and gE genes was transcribed and translated into a precursor
polypeptide (Fig. 3A). The gD precursor
polypeptide was about 43 kDa, close to the mass predicted from its
amino acid sequence.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
Expression of MDV gD and other MDV Us genes
by in vitro -coupled transcription-translation. (A) Direct SDS-PAGE
analysis, 12-h exposure. Lanes 1, without DNA template; 2, MDV SORF4
gene template; 3, MDV gD gene template; MDV gI gene template; 5, MDV gE
gene template; 6, luciferase gene template. (B) Immunoprecipitation
analysis prior to SDS-PAGE; 3-day exposure. Lanes 1, precursor
polypeptide of glycoprotein gD immunoprecipitated by anti-gD; 2, precursor polypeptide of glycoprotein gI immunoprecipitated by anti-gI;
3, precursor polypeptide of glycoprotein gE immunoprecipitated by
anti-gE.
|
|
Failure to detect gD expression in MDV-infected cells by
immunoprecipitation could result from failure of the antibody to recognize gD. To confirm that the anti-gD antibody is reactive with gD
protein, an immunoprecipitation analysis was conducted with the gD, gI,
and gE precursor polypeptides produced by in vitro-coupled
transcription-translation and their respective antisera. While three
antisera to different gD fragments were used (Fig. 1), only antibody
against the gD fragment encoded by nucleotides 7501 to 8154 was able to
react with the gD precursor polypeptide (Fig. 3B, negative data not
shown). This antibody also recognizes the glycosylated form of gD
(unpublished data). This anti-gD antiserum had been used in the
previous immunoprecipitation analysis (Fig. 2).
Successful detection of the gD precursor polypeptide produced by in
vitro-coupled transcription-translation demonstrated that the MDV gD
gene encodes a complete gD protein. Therefore, the absence of
detectable MDV gD expression in cell culture may be due to inefficient
gD transcription, ineffective translation, or both.
Northern blot analysis of mRNA from MDV-infected cells using DNA
probes.
Like other alphaherpesvirus homologs, the MDV gD (US6), gI
(US7), and gE (US8) genes are clustered in that order within the unique
short region of the viral genome, spanning nucleotides 6943 to 10960 (Fig. 1) (3). One poly(A) terminator sequence, AATAAA, is
located upstream of US6 (gD), and another AATAAA sequence is located
downstream of US8 (gE). There is no such sequence downstream of US6
(gD) or US7 (gI). In eucaryotic systems, the protein is most probably
translated from the first favorable ATG of an mRNA. Therefore, for
efficient expression of the MDV gD or gI genes, mRNA which starts just
upstream of the gD gene or the gI gene should exist. However, if MDV gD
expression is down-regulated at the transcription level, the
gD-specific transcript may not be detectable.
To characterize transcripts of the MDV gD, gI, and gE genes, Northern
blot analysis was done with mRNA from MDV GA-infected DEF cells, with
RNA from mock-infected DEF cells used as a negative control. Fragments
of each of the genes, which had previously been used to make the TrpE
fusion protein, were used to make double-stranded DNA probes for
Northern blot analysis. The gD probe included nucleotides 7398 to 7797 from US6 (gD), the gI probe included nucleotides 8374 to 8804 from US7
(gI), and the gE probe included nucleotides 9773 to 10574 from US8 (gE)
(Fig. 1).
The gD probe did not hybridize with any abundant mRNA (Fig.
4, lane 2), which may account for the
failure to detect the MDV gD protein by immunoprecipitation. The gI
probe hybridized with an abundant 3.5-kb mRNA that was also detected by
the gE probe. In addition, the gE probe hybridized with another 2.0-kb
transcript, which may be 3'-coterminal with the 3.5-kb transcript. When
the blots were subjected to overexposure, a low-abundance large
fragment of about 7.5 kb was barely detected by the gD, gI, and gE
probes (data not shown). Thus, an explanation of the 7.5-kb fragment requires further study.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 4.
Northern blot analysis of mRNA from MDV-infected cells
with DNA probes; 3-day exposure. Lanes 1, 3, and 5, uninfected DEF; 2, 4, and 6, MDV GA-infected DEF; 1 and 2; hybridized with an MDV
gD-specific probe; 3 and 4, hybridized with an MDV gI-specific probe; 5 and 6, hybridized with an MDV gE-specific probe. The 7.5- to 8-kb band
was of very low abundance and was seen only after a 10- to 12-day
exposure (data not shown).
|
|
RT-PCR analysis of the MDV gD, gI, and gE transcripts.
To
confirm the existence of a low-abundance polycistronic transcript that
includes the gD gene, RT-PCR was performed with DNase I-treated total
RNA from MDV-infected DEF cells. First-strand cDNA was synthesized in
the reverse transcription reaction, and this was followed by PCR. In
the control experiment, the same procedure was performed, except that
no RT was added in the cDNA synthesis step. The primers from the gD
gene are designated DS (D sense) and DA (D antisense), the primers from
the gI gene are designated IS and IA, and the primers from the gE gene
are designated ES and EA (Fig. 5A).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 5.
RT-PCR analysis of MDV gD transcription in MDV-infected
cells. (A) Nucleotide positions in the MDV Us region
encompassing gD, gI, and gE. DS, primer gD sense, DA, primer gD
antisense; IS, primer gI sense; IA, primer gI antisense; ES, primer gE
sense; EA, primer gE antisense. The nucleotide position numbers are as
previously published (3). (B) Gene-specific primer pairs.
Lanes: 1, 3, and 5, reaction in the absence of RT; 2, 4, and 6, reaction in the presence of RT Left marker: /HindIII marker. Right
marker: 123-bp ladder. (C) Primer pairs spanning two or more genes.
Lanes: 7, 9, and 11, Reaction in the absence of RT; 8, 10, and 12, Reaction in the presence of RT. Left marker: /HindIII
marker. Right marker: 1-kb ladder.
|
|
When gene-specific pairs of primers were used in the RT-PCR
amplification, all of the gD, gI, and gE cDNA fragments were amplified to the sizes expected from their DNA sequences (Fig. 5B). Reaction with
primers DS/DA produced a DNA fragment of about 550 bp; reaction with
primers IS/IA produced a fragment of about 600 bp; and reaction with
primers ES/EA produced a fragment of about 480 bp. Since no product was
found in each control experiment (Fig. 5B, lanes (1, 3 and
5), the positive RT-PCR data did not come from carryover of
viral DNA. This result indicated that there is a low-abundance
transcript which includes the gD gene.
Instead of gene-specific primer pairs, primers from two different genes
were used in pairs in the following RT-PCR amplification. When primer
pair IS/EA, which spans the gI and gE genes, was used, a DNA fragment
of about 1,700 bp was produced (Fig. 5C, lane 8). This result was
consistent with a gI-gE bicistronic transcript. When primer pair DS/IA,
spanning the gD and gI genes, was used, a DNA fragment of about 1,800 bp was produced. Further, when the DS/EA primer pair, spanning the gD,
gI, and gE genes, was used, a DNA fragment of about 2,900 bp was
produced. These results were consistent with the presence of
polycistronic transcript including the gD, gI, and gE genes.
Northern blot analysis of mRNA from MDV-infected cells using
riboprobes.
To further characterize the low-abundance large
transcript, a more sensitive Northern blot analysis was performed with
riboprobes and a larger amount of mRNA. MDV-infected CEF cells were
used instead of DEF cells in this experiment to determine if the
transcription pattern was different between these two cell culture systems.
In the MDV Us region, the SORF3 and US2 genes are leftward
oriented while the US3, SORF4, gD, gI, and gE genes are rightward oriented (Fig. 1) (3). DNA fragments including each gene
were cloned between the T7 and T3 promoters so that riboprobes could be
synthesized. All of the riboprobes were generated as leftward oriented.
Thus, they were in antiparallel to the US3, SORF4, gD, gI, and gE genes
but parallel to the US2 and SORF3 genes. The US2 probe included
nucleotides 3747 to 4837, the US3 probe included nucleotides 4865 to
6269, the SORF4 probe included nucleotides 6334 to 6922, the gD probe
included nucleotides 6943 to 8157, the gI probe included nucleotides
8195 to 9354, and the gE probe included nucleotides 9443 to 10973.
Because riboprobes are much more sensitive than DNA probes and because
four times more mRNA was used in these experiments than in the previous
Northern blot analysis with DNA probes, the low-abundance 7.5-kb
transcript was now more readily detected and analyzed (Fig.
6A, lane 8). Comparing this Northern blot
experiment with the previous one, both the gI-gE bicistronic 3.5-kb
transcript and the gE-specific 2.0-kb transcript were detected (Fig. 4
and 6A), as expected. A less abundant gE-specific 4.4-kb transcript was
also detected by this more sensitive method (Fig. 6B, lane 12).
However, after 12 h of exposure the same blot clearly showed only
the very abundant 3.5- and 2.0-kb transcripts (data not shown). The
low-abundance species would appear to have little significance in the
synthesis of gE. Thus, the transcription pattern is very similar
between the MDV-infected -CEF cells and DEF cells.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 6.
Northern blot analysis of mRNA from MDV-infected cells
using riboprobes. Lanes: 1, 3, 5, 9, and 11, uninfected CEF cells; 2, 4, 6, 8, 10, and 12, MDV GA-infected CEF cells; 1 and 2, hybridized
with a riboprobe which is in the same orientation as the US2 gene; 3 and 4, hybridized with an MDV US3-specific riboprobe; 5 and 6, hybridized with an MDV SORF4-specific riboprobe; 7 and 8, hybridized
with an MDV gD-specific riboprobe; 9 and 10, hybridized with an MDV
gI-specific riboprobe; 11 and 12, hybridized with an MDV gE-specific
riboprobe. (A) One-day exposure. (B) Four-day exposure.
|
|
After a fourfold-longer exposure, the 7.5-kb transcript was detected by
the US3, SORF4, gD, gI, and gE riboprobes but not by the US2 probe
(Fig. 6B). Therefore, the low-abundance large transcript detected by
the gD probe does not initiate immediately 5' of the gD gene but from
two ORFs upstream of the gD gene. The 7.5-kb transcript is unlikely to
be translated into the gD protein.
RNase protection analysis of the MDV gI and gE transcripts.
In
contrast to the gD gene, the gI and gE genes are transcribed
efficiently in MDV-infected cells. To confirm the lack of a gD promoter
and to determine the promoter regions and 3' termini of the gI and gE
transcripts, RNase protection analysis was performed. A series of
subgenomic fragments inclusive of ATG sites or AATAAA sequences were
subcloned into pBCSK(+) plasmids. A series of riboprobes complementary
to mRNA were generated (Fig. 7A),
hybridized to RNA obtained from mock-infected and MDV-infected cells
72 h postinfection, digested with RNase, and analyzed on
sequencing gels. The size of each fragment was calculated based on a
comparison with the synthesized RNA marker. No gD gene-specific
promoter region could be detected by this method (data not shown).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 7.
RNase protection assays of RNAs from MDV-infected cells.
(A) Locations of probes used for RNase protection. The number adjacent
to each probe indicates the distance (in nucleotides) away from the
first nucleotide of each ORF. aa, amino acids. (B) CON, RNA from
mock-infected DEF cells; INF, RNA from MDV GA-infected DEF cells; M,
RNA markers.
|
|
To determine the initiation site proximal to the gI gene, plasmid pBCB1
was constructed. This plasmid contains a 215-bp insert spanning
sequences 183 bp upstream to 32 bp downstream of the gI ATG site (Fig.
7A). After digestion with EcoRI, this plasmid could be used
to generate a 215-nucleotides antisense probe. RNase protection
produced an abundant fragment of 55 nucleotides (Fig. 7B, gI 5'). The
size of this product was consistent with an initiation site located 23 nucleotides upstream of the gI ATG site. The result suggests that this
transcript is the source of the 3.5-kb gI-gE bicistronic mRNA (Fig.
8). Another, larger fragment (215 bp) was also protected and was probably due to protection from the
low-abundance 7.5-kb transcript.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 8.
MDV transcript termini deduced from Northern blot
analysis and RNase protection analysis. Dotted lines indicate the 5'
and 3' ends of each transcript. There are two possible 3' termini for
each transcript.
|
|
To map the initiation site proximal to the gE gene, plasmid pBCKV1 was
constructed. The plasmid contains a 226-bp insert spanning the gE ATG
site. After digestion with BanI, this plasmid could be used
to generate a 226-nucleotide antisense probe initiating 118 nucleotides
within the gE gene and extending to 108 nucleotides upstream of the gE
ATG codon (Fig. 7A). The full-length fragment derived from RNase
protection might result from the 3.5-kb gI-gE bicistronic transcript
and/or the low-abundance 7.5-kb polycistronic transcripts. In addition,
a smaller fragment (142 nucleotides) was protected (Fig. 7B, gE 5').
The size of this fragment indicates a transcription initiation site 24 nucleotides upstream of the gE ATG site. The result suggests that the
gE-specific transcript is the 2.0-kb mRNA (Fig. 8).
Because an AATAAA sequence is located downstream of the gE gene, but
not of the gI gene, only one riboprobe was needed to map the 3' termini
of these transcripts. Plasmid pBCSm4, which contains a 209-bp insert
spanning sequences 45 bp upstream to 164 bp downstream of the AATAAA
sequence, was constructed (Fig. 7A). After digestion with
EcoRI, this plasmid could be used to generate a 209-base
antisense probe. The probe protected two fragments of 53 and 129 nucleotides (Fig. 7B, 3'). The 129-nucleotide fragment was consistent
with transcripts terminating 94 nucleotides downstream of the AATAAA
site. The 53-base fragment indicated a transcript terminus 8 nucleotides downstream of the AATAAA site (Fig. 8). It is likely that
both the 3.5- and 2.0-kb transcripts can terminate at either site.
 |
DISCUSSION |
This study confirmed that MDV gD expression is below the limit of
detection in MDV-infected cell culture and showed that this is because
of inefficient gD gene-specific transcription. The only transcript
clearly detected by the gD gene probe initiates two ORFs upstream of
the gD gene. Research on HSV-1 has revealed that each viral gene has
its own promoter and that each transcript contains a single functional
ORF. Although some HSV-1 mRNAs contain additional protein-coding
sequences downstream of their primary ORFs, proteins are not translated
from these downstream regions. Instead, abundant proteins are
translated from the mRNAs initiating immediately 5' to their genes
(22), consistent with the overwhelmingly monocistronic
nature of eukaryotic genes. Thus, a priori, the possibility of
significant gD gene translation from the 7.5-kb transcript is very unlikely.
HSV-1 gD gene transcription initiates about 85 nucleotides upstream of
its ATG codon. Two TATA motifs are located 108 and 126 nucleotides 5'
to the ATG codon. Furthermore, DNA within the 168 nucleotides upstream
is required for regulated expression of the HSV-1 gD gene, and the
consensus ICP4 binding motif ATCGTC is found in this region
(21). In the upstream region of the MDV gD gene, three
TATA motifs are located at 27, 36, and 50 nucleotides 5' to the ATG
codon. No ICP4 binding motif is found there. A consensus poly(A) signal
AATAAA sequence is located 60 nucleotides 5' to the gD start codon,
which is very close to the TATA motifs. The proximity of the AATAAA
sequence may destabilize the transcription initiation complex formed on
the TATA sequences and abort the transcription initiation from the gD gene.
MDV gI gene transcription is initiated 23 nucleotides 5' to its ATG
site, in contrast to its homolog, the HSV-1 gI transcript, which is
initiated 91 nucleotides 5' to its ATG site. Similarly, the MDV gE
untranslated region is 24 bases long, only one-third the length of its
HSV-1 homolog (73 bases). Considering that the region between MDV gD
and gI genes and the region between the gI and gE genes are much
shorter than the corresponding regions among the HSV-1 gD, gI, and gE
genes, the relatively shorter untranslated regions of MDV gI and gE
transcripts are expected.
Either the TATATA sequence or the TATAG sequence upstream of the gI
gene CAP site may serve as the TATA box for transcription initiation.
Similarly, the TATAT sequence, the TTTAAA sequence, or the TATAA
sequence upstream of the gE initiation site may serve as the TATA box
for gE transcription initiation. Since the 5' termini of the gI and gE
transcripts have been mapped by the RNase protection assay, their
promoter regions have been identified and can be studied. The VZV gpIV
(gI homolog) promoter has a very low basal level of transcription, but
viral factors or virus-induced factors can significantly activate its
promoter activity (19). Whether the MDV gI and gE
promoters share similar features remains to be determined.
The 2.0- and 3.5-kb transcripts of gI and gE appear to coterminate at a
typical AATAAA motif. It is very common among alphaherpesvirus transcription that one polyadenylation signal is shared by several genes, each initiating from its own promoter (17, 22). Two possible 3' termini of the gI and gE transcripts were identified in the
RNase protection assay. Heterogeneous 3' ends have been described
previously for the VZV gpIV (gI homolog) transcript (19).
It is very likely that both the 2.0-kb and 3.5-kb transcripts can
terminate at either site.
Because Fig. 6 is a composite made up from the development of 12 different films, those that had been fixed somewhat longer have a
darker background (Fig. 6A lanes 7 and 8; Fig. 6B, lanes 1, 2, 9, and
10). Longer exposure of the Northern blot showed several very low
abundance fragments smaller than the low-abundance 7.5-kb transcript
(Fig. 6B, lanes 4, 6, and 8). These signals may represent
nonspecifically hybridized RNA or may represent transcripts present in
extremely low abundance. Translation from these uncharacterized
transcripts and leaky scanning translation from the 7.5-kb transcript
may be able to produce very few gD molecules. Nonetheless, even if
these rare translations take place, the few gD molecules could play no
significant role in MDV infection. This notion is supported by a study
by Morgan's group in which an MDV gD lacZ insertion mutant
was made which had similar growth kinetics to the wild-type MDV in both
cell culture and chickens (1, 25).
Among the other alphaherpesviruses, HSV-1 has an essential gD gene;
VZV, a highly cell-associated virus, lacks a gD homolog altogether; and
PRV and BHV-1 are cell-free viruses, but their gD mutants become cell
associated, although their infectivity is greatly impaired (12,
18, 28). In keeping with these observations, MDV, a highly
cell-associated virus in cell culture, lacks detectable gD expression
in cell culture. The FFE of MDV-infected chickens is the only known
tissue producing cell-free virus, and whether MDV gD is expressed
there is a very interesting question. To address this question, other
groups have made monoclonal antibody and detected MDV-gD expression in
a few feather follicles (24).
Whether the MDV gD expression phenomenon (perhaps limited only to a few
FFE cells) is unique to gD or whether other MDV genes also exhibit this
pattern needs to be characterized, and related mechanisms need to be
further explored. Learning from research on HSV-1, we can assume that
there are specific cellular receptors for MDV. However, since currently
known HSV-1 receptors bind to gD, the receptors for MDV probably are of
a different type or react with a different viral protein.
 |
ACKNOWLEDGMENTS |
This research was supported by the State of Michigan Research
Excellence Fund, through Michigan State University's Center for Animal
Production Enhancement, and by the Cooperative State Research Service,
U.S. Department of Agriculture, under Agreement 90-37266-5589.
We thank Ruth A. Vrable for excellent technical assistance. The
critical reading of the manuscript by Bill MacCarthur, Robert Silva,
Masahiro Niikura, and Calvin Keeler is appreciated. X.T. also thanks
guidance committee members Paul Coussens, Don Salter, Roger Maes, and
Richard Schwartz for careful reviews of the manuscript and many helpful suggestions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Animal and Food Sciences, University of Delaware, Newark, DE
19717-1303. Phone: (302) 831-8794. Fax: (302) 831-2822. E-mail:
tanxinyu{at}udel.edu.
Dedicated to the memory of Leland F. Velicer, who passed away on 27 December 2000.
Present address: Department of Molecular and Microbiology, Case
Western Reserve University, Cleveland, OH 44106-4960.
§
Deceased.
 |
REFERENCES |
| 1.
|
Anderson, A. S.,
M. S. Parcells, and R. W. Morgan.
1998.
The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus.
J. Virol.
72:2548-2553[Abstract/Free Full Text].
|
| 2.
|
Brunovskis, P.,
X. Chen, and L. F. Velicer.
1992.
Analysis of Marek's disease virus glycoproteins D, I and E, p. 118-122.
In
Proceedings of the 19th World's Poultry Congress, vol. 1. 4th International Symposium on Marek's Disease. Part Posen and Looijen, Wageningen, The Netherlands.
|
| 3.
|
Brunovskis, P., and L. F. Velicer.
1995.
The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes.
Virology
206:324-338[CrossRef][Medline].
|
| 4.
|
Burke, R. L.
1993.
HSV vaccine development, p. 367-380.
In
B. Roizman, and C. Lopez (ed.), The herpesviruses. Raven Press, New York, N.Y.
|
| 5.
|
Calnek, B. W., and R. L. Witter.
1991.
Marek's disease, p. 342-385.
In
B. W. Calnek (ed.), Diseases of poultry. Iowa State University Press, Ames.
|
| 6.
|
Card, J. P.,
M. E. Whealy,
A. K. Robbins, and L. W. Enquist.
1992.
Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system.
J. Virol.
66:3032-3041[Abstract/Free Full Text].
|
| 7.
|
Chase, C. C. L.,
K. Carter-Allen,
C. Lohff, and G. Letchworth, III.
1990.
Bovine cells expressing bovine herpesvirus 1 glycoprotein IV resist infection by BHV-1, herpes simplex virus, and pseudorabies virus.
J. Virol.
64:4866-4872[Abstract/Free Full Text].
|
| 8.
|
Chen, X., and L. F. Velicer.
1992.
Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigen.
J. Virol.
66:4390-4398[Abstract/Free Full Text].
|
| 9.
|
Cui, Z.,
Y. You, and L. F. Lee.
1992.
Identification and localization of the Marek's disease virus group-common antigen p79 gene, p. 89-92.
In
Proceedings of the 19th World's Poultry Congress, vol. 1. 4th International Symposium on Marek's Disease. Part, Pasen and Luoijen, Wageningen, The Netherlands.
|
| 10.
| Davison, A. J. (ed.). 1993. HSV and other
alphaherpesviruses. Semin. Virol. 4.
|
| 11.
|
Fuller, A. O., and W.-C. Lee.
1992.
Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration.
J. Virol.
66:5002-5012[Abstract/Free Full Text].
|
| 12.
|
Heffner, S.,
F. Kovacs,
B. G. Klupp, and T. C. Mettenleiter.
1993.
Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.
J. Virol.
67:1529-1537[Abstract/Free Full Text].
|
| 13.
|
Isfort, R. J.,
I. Sithole,
H. Kung, and L. F. Velicer.
1986.
Molecular characterization of Marek's disease herpesvirus B antigen.
J. Virol.
59:411-419[Abstract/Free Full Text].
|
| 14.
|
Johnson, D. C.,
M. C. Frame,
M. W. Ligas,
A. M. Cross, and N. G. Stow.
1988.
Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI.
J. Virol.
62:1347-1354[Abstract/Free Full Text].
|
| 15.
|
Johnson, D. C., and M. W. Ligas.
1988.
Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors.
J. Virol.
62:4605-4612[Abstract/Free Full Text].
|
| 16.
|
Johnson, R. M., and P. G. Spear.
1989.
Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection.
J. Virol.
63:819-827[Abstract/Free Full Text].
|
| 17.
|
Kinchington, P. R.,
J. Vergnes,
P. Defechereux,
J. Piette, and S. E. Turse.
1994.
Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63.
J. Virol.
68:3570-3581[Abstract/Free Full Text].
|
| 18.
|
Liang, X.,
C. Pyne,
Y. Li,
L. A. Babiuk, and J. Kowalski.
1995.
Delineation of the essential function of bovine herpesvirus 1 gD: an indication for the modulatory role of gD in virus entry.
Virology
207:429-441[CrossRef][Medline].
|
| 19.
|
Ling, P.,
P. R. Kimchington,
M. Sadeghi-zadeh,
W. T. Ruyechan, and J. Hay.
1992.
Transcription from varicella-zoster virus gene 67 (glycoprotein IV).
J. Virol.
66:3690-3698[Abstract/Free Full Text].
|
| 20.
|
Litwin, V.,
W. Jackson, and C. Grose.
1992.
Receptor property of two varicella-zoster virus glycoproteins gpI and gpIV homologous to herpes simplex virus gE and gI.
J. Virol.
66:3643-3651[Abstract/Free Full Text].
|
| 21.
|
McGeoch, D. J.,
A. Dolan,
S. Donald, and F. J. Rixon.
1985.
Sequence determination and genetic content of the short unique region in the genome of HSV1.
J. Mol. Biol.
181:1-13[CrossRef][Medline].
|
| 22.
|
McGeoch, D. J.
1992.
Correlation between HSV-1 DNA sequence and viral transcription maps.
In
E. K. Wagner (ed.), Herpesvirus transcription and its regulation. CRC Press, Inc., Boca Raton, Fla.
|
| 23.
|
Neidhardt, H.,
C. H. Schroder, and H. C. Kaerner.
1987.
Herpes simplex virus type 1 glycoprotein E is not indispensable for viral infection.
J. Virol.
61:600-603[Abstract/Free Full Text].
|
| 24.
|
Niikura, M.,
R. L. Witter,
H-K Jang,
M Ono,
T Mikami, and R. F. Silva.
1999.
MDV glycoprotein D is expressed in the feather follicle epithelium of infected chickens.
Acta Virol.
43:159-163[Medline].
|
| 25.
|
Parcells, M. S.,
A. S. Anderson, and R. W. Morgan.
1994.
Characterization of a Marek's disease virus mutant containing a LacZ insertion in the US6 (gD) homolog gene.
Virus Genes
9:5-13[CrossRef][Medline].
|
| 26.
|
Peeters, B.,
J. Pol,
A. Gielkens, and R. Moormann.
1993.
Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice.
J. Virol.
67:170-177[Abstract/Free Full Text].
|
| 27.
|
Petrovskis, E. A.,
A. L. Meyer, and L. E. Post.
1988.
Reduced yield of infectious pseudorabies virus and herpes simplex virus from cell lines producing viral glycoprotein gp50.
J. Virol.
62:2196-2199[Abstract/Free Full Text].
|
| 28.
|
Rauh, I., and T. C. Mettenleiter.
1991.
Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration.
J. Virol.
65:5348-5356[Abstract/Free Full Text].
|
| 29.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, New York, N.Y.
|
Journal of Virology, March 2001, p. 2067-2075, Vol. 75, No. 5
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.5.2067-2075.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Che, X., Berarducci, B., Sommer, M., Ruyechan, W. T., Arvin, A. M.
(2007). The Ubiquitous Cellular Transcriptional Factor USF Targets the Varicella-Zoster Virus Open Reading Frame 10 Promoter and Determines Virulence in Human Skin Xenografts in SCIDhu Mice In Vivo. J. Virol.
81: 3229-3239
[Abstract]
[Full Text]
-
Tischer, B. K., Schumacher, D., Chabanne-Vautherot, D., Zelnik, V., Vautherot, J.-F., Osterrieder, N.
(2005). High-Level Expression of Marek's Disease Virus Glycoprotein C Is Detrimental to Virus Growth In Vitro. J. Virol.
79: 5889-5899
[Abstract]
[Full Text]
-
Tischer, B. K., Schumacher, D., Messerle, M., Wagner, M., Osterrieder, N.
(2002). The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J. Gen. Virol.
83: 997-1003
[Abstract]
[Full Text]
-
Schumacher, D., Tischer, B. K., Reddy, S. M., Osterrieder, N.
(2001). Glycoproteins E and I of Marek's Disease Virus Serotype 1 Are Essential for Virus Growth in Cultured Cells. J. Virol.
75: 11307-11318
[Abstract]
[Full Text]